Search research articles
Contact Us
Filters
Showing results (11-20 of 487) with videos related to
Page
of 49
Sort By:
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology
|
August 20, 2016
Sec16 at transitional ER sites: Still a model (retrospective on DOI 10.1002/bies.201300131)
Ken Sato
Genes to Cells : Devoted to Molecular & Cellular Mechanisms
|
January 28, 2009
O-Mannosylation is required for the solubilization of heterologously expressed human beta-amyloid precursor protein in Saccharomyces cerevisiae
Akiko Murakami-Sekimata, Ken Sato, Ken Sato, et al.
Tanpakushitsu Kakusan Koso. Protein, Nucleic Acid, Enzyme
|
November 3, 2010
[C. elegans, an amenable model system for the study of membrane trafficking in living animals]
Miyuki Sato, Ken Sato
Journal of Cell Science
|
May 9, 2023
Sec16 and Sed4 interdependently function as interaction and localization partners at ER exit sites
Tomohiro Yorimitsu, Ken Sato
Methods in Enzymology
|
January 18, 2006
Reconstitution of cargo-dependent COPII coat assembly on proteoliposomes
Ken Sato, Akihiko Nakano
The Journal of Biological Chemistry
|
November 25, 2003
Reconstitution of coat protein complex II (COPII) vesicle formation from cargo-reconstituted proteoliposomes reveals the potential role of GTP hydrolysis by Sar1p in protein sorting
Ken Sato, Akihiko Nakano
Molecular Biology of the Cell
|
July 15, 2003
Oligomerization of a cargo receptor directs protein sorting into COPII-coated transport vesicles
Ken Sato, Akihiko Nakano
Molecular Biology of the Cell
|
June 8, 2012
Insights into structural and regulatory roles of Sec16 in COPII vesicle formation at ER exit sites
Tomohiro Yorimitsu, Ken Sato
Traffic (Copenhagen, Denmark)
|
January 30, 2013
Dynamic regulation of autophagy and endocytosis for cell remodeling during early development
Miyuki Sato, Ken Sato
Diabetic Medicine : a Journal of the British Diabetic Association
|
July 3, 2021
Successful withdrawal of erythropoiesis-stimulating agent after administration of an SGLT2 inhibitor, tofogliflozin, in people with diabetes
Ken Sato, Tetsuya Babazono
Page
of 49
Search research articles
Search
Showing results (11-20 of 487) with videos related to
Sort By:
Page
of 49
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology
|
August 20, 2016
Sec16 at transitional ER sites: Still a model (retrospective on DOI 10.1002/bies.201300131)
Ken Sato
Genes to Cells : Devoted to Molecular & Cellular Mechanisms
|
January 28, 2009
O-Mannosylation is required for the solubilization of heterologously expressed human beta-amyloid precursor protein in Saccharomyces cerevisiae
Akiko Murakami-Sekimata, Ken Sato, Ken Sato, et al.
Tanpakushitsu Kakusan Koso. Protein, Nucleic Acid, Enzyme
|
November 3, 2010
[C. elegans, an amenable model system for the study of membrane trafficking in living animals]
Miyuki Sato, Ken Sato
Journal of Cell Science
|
May 9, 2023
Sec16 and Sed4 interdependently function as interaction and localization partners at ER exit sites
Tomohiro Yorimitsu, Ken Sato
Methods in Enzymology
|
January 18, 2006
Reconstitution of cargo-dependent COPII coat assembly on proteoliposomes
Ken Sato, Akihiko Nakano
The Journal of Biological Chemistry
|
November 25, 2003
Reconstitution of coat protein complex II (COPII) vesicle formation from cargo-reconstituted proteoliposomes reveals the potential role of GTP hydrolysis by Sar1p in protein sorting
Ken Sato, Akihiko Nakano
Molecular Biology of the Cell
|
July 15, 2003
Oligomerization of a cargo receptor directs protein sorting into COPII-coated transport vesicles
Ken Sato, Akihiko Nakano
Molecular Biology of the Cell
|
June 8, 2012
Insights into structural and regulatory roles of Sec16 in COPII vesicle formation at ER exit sites
Tomohiro Yorimitsu, Ken Sato
Traffic (Copenhagen, Denmark)
|
January 30, 2013
Dynamic regulation of autophagy and endocytosis for cell remodeling during early development
Miyuki Sato, Ken Sato
Diabetic Medicine : a Journal of the British Diabetic Association
|
July 3, 2021
Successful withdrawal of erythropoiesis-stimulating agent after administration of an SGLT2 inhibitor, tofogliflozin, in people with diabetes
Ken Sato, Tetsuya Babazono
Page
of 49